Local Institution - 1002

New York, New York 10065

0 studies enrolling now · 1 studies all time

What they study most

Locally Advanced Solid Tumors, Metastatic Solid Tumors

Studies at this site

• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — Recruiting now